These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8324333)

  • 1. Prognostic factors for local recurrence in breast conservation therapy: residual cancers after lumpectomy.
    Fukutomi T; Yamamoto H; Nanasawa T; Itabashi M; Hirota T
    Surg Today; 1993; 23(5):402-6. PubMed ID: 8324333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems of breast conservation therapy--residual cancers after lumpectomy and effects of preoperative radiotherapy].
    Fukutomi T
    Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():212-6. PubMed ID: 8037484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity.
    Fisher ER; Sass R; Fisher B; Gregorio R; Brown R; Wickerham L
    Cancer; 1986 May; 57(9):1717-24. PubMed ID: 2856856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned segmentectomy. A necessity for breast carcinoma.
    Tafra L; Guenther JM; Giuliano AE
    Arch Surg; 1993 Sep; 128(9):1014-8; discussion 1018-20. PubMed ID: 8396387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lumpectomy margins, reexcision, and local recurrence of breast cancer.
    Tartter PI; Kaplan J; Bleiweiss I; Gajdos C; Kong A; Ahmed S; Zapetti D
    Am J Surg; 2000 Feb; 179(2):81-5. PubMed ID: 10773138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy.
    Vora SA; Wazer DE; Homer MJ
    Radiology; 1997 Jun; 203(3):667-71. PubMed ID: 9169686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy.
    Sioshansi S; Ehdaivand S; Cramer C; Lomme MM; Price LL; Wazer DE
    Cancer; 2012 Aug; 118(16):3893-8. PubMed ID: 22864932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological study of local residual carcinoma after simulated lumpectomy.
    Haga S; Makita M; Shimizu T; Watanabe O; Imamura H; Kajiwara T; Fujibayashi M
    Surg Today; 1995; 25(4):329-33. PubMed ID: 7633124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements.
    Faverly DR; Hendriks JH; Holland R
    Cancer; 2001 Feb; 91(4):647-59. PubMed ID: 11241230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rates in patients with central or retroareolar breast cancers treated with mastectomy or lumpectomy.
    Simmons RM; Brennan MB; Christos P; Sckolnick M; Osborne M
    Am J Surg; 2001 Oct; 182(4):325-9. PubMed ID: 11720664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopsy findings after breast conservation therapy for early-stage invasive breast cancer.
    Vapiwala N; Starzyk J; Harris EE; Tchou JC; Boraas MC; Czerniecki BJ; Rosato EF; Orel SG; Solin LJ
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):490-7. PubMed ID: 17544594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
    Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
    Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology and treatment of impalpable breast lesions.
    Radford DM; Cromack DT; Troop BR; Keller SM; Lopez MJ
    Am J Surg; 1992 Nov; 164(5):427-31; discussion 431-2. PubMed ID: 1332522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study.
    Mestak O; Hromadkova V; Fajfrova M; Molitor M; Mestak J
    Ann Surg Oncol; 2016 Mar; 23(3):776-81. PubMed ID: 26467459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
    Giess CS; Keating DM; Osborne MP; Rosenblatt R
    Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.